👀 Copy Legendary Investors' Portfolios in One ClickCopy For Free

Nib Holdings stock downgraded to Hold by Jefferies following underwhelming guide

Published 11/12/2024, 11:32 PM
Updated 11/12/2024, 11:34 PM
NHF
-

On Tuesday, nib Holdings Ltd. (NHF:AU) (OTC: NIBHF) experienced a change in stock rating as Jefferies shifted its stance from Buy to Hold. The financial services firm also adjusted the price target on the company's shares to AUD6.60, down from the previous AUD7.10.

The downgrade comes after nib Holdings provided financial guidance for the fiscal year 2025, projecting an underlying operating profit between AUD235 million and AUD250 million. This forecast represents a 5.8% drop from the prior corresponding period at the midpoint.

The initial four months of the fiscal year 2025 have shown a higher-than-average policy growth for Australian residents' health insurance (arhi) but also an increase in claims in New Zealand that exceeded expectations.

Jefferies noted the effect of claims inflation for the fiscal year 2025 is anticipated to be more significant than previously estimated. This has led to the revision of the price target to AUD6.60, indicating a more cautious outlook on the company's financial performance.

The analyst from Jefferies highlighted the contrast in nib Holdings' performance, with strong policy growth on one hand and higher claims on the other, particularly in New Zealand. The reassessment of the impact of claims inflation is a key factor in the revised rating and price target. The new price target of AUD6.60, down from AUD7.10, reflects the firm's adjusted expectations for nib Holdings.

InvestingPro Insights

Adding to the analysis of nib Holdings Ltd. (NHF:AU), recent data from InvestingPro provides additional context to the company's financial situation and market performance. Despite the downgrade from Jefferies, nib Holdings maintains some positive financial indicators.

According to InvestingPro data, nib Holdings has a market capitalization of 1.9 billion USD and is trading at a P/E ratio of 15.67. This relatively low P/E ratio, especially when considered alongside the company's near-term earnings growth potential, suggests that the stock may be undervalued. This is further supported by an InvestingPro Tip indicating that the company is "trading at a low P/E ratio relative to near-term earnings growth."

The company's revenue growth of 9.3% over the last twelve months aligns with the reported strong policy growth in Australian residents' health insurance. However, the gross profit margin of 13.57% is relatively low, which is reflected in another InvestingPro Tip stating that the company "suffers from weak gross profit margins." This could be a contributing factor to the concerns about claims inflation highlighted in the Jefferies analysis.

On a positive note, nib Holdings has maintained dividend payments for 17 consecutive years, as noted by an InvestingPro Tip. With a current dividend yield of 4.87%, this could be an attractive feature for income-focused investors, especially given the recent price decline of 15.68% over the past three months.

For investors seeking a more comprehensive analysis, InvestingPro offers 8 additional tips for nib Holdings, providing a deeper understanding of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.